Skip to main content
Glama

Microsoft Onenote

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark it read-only/idempotent, but the description adds substantial behavior: ambiguity returns figi_candidates, unresolvable identifiers appear under unresolved rather than being omitted, source labels accompany each identifier, and LEI/FIGI enrichment degrades gracefully when upstream providers are unavailable. No annotation contradiction.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with examples and a core rule, but the body is a dense wall of nested parentheticals that is harder to scan than it should be. Most content earns its place, yet structure and readability are sacrificed.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description compensates well: it enumerates the returned identifiers per type (CIK, ticker, LEI, FIGI, RxCUI, ingredient, brand), explains the citation format, and covers unresolved/ambiguous cases. For a complex multi-source resolution tool, this is sufficient for correct invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description goes well beyond the schema: it explains the entity-name-only rule with a concrete bond issuer example, warns that trailing security-class words match nothing, and clarifies how an ISIN resolves to the legal entity through GLEIF. This materially improves the agent's chance of passing correct values.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb and resource: resolve a user-spoken name to canonical/official identifiers required by other tools. It also provides a clear first-step rule ('Use FIRST whenever you have a name but need an ID'), which separates it from downstream profile/validation siblings like entity_profile and validate_claim.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says to use this tool FIRST whenever a name needs resolving to an ID, and gives supported entity types with input formats. However, it does not name excluded alternatives or say what to do when the user already has an identifier and wants a profile, so it stops short of a full when/when-not comparison.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Microsoft Onenote toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.5/5.0
Disambiguation2/5

Several tools are genuinely easy to confuse: ask_pipeworx and ask_pipeworx_beta are explicitly described as currently identical, and the five polymarket_* tools overlap significantly in purpose. There are also wrapper-like pairs such as ai_visibility_check vs. scan_competitor_ai_presence and entity_profile vs. recent_changes vs. compare_entities that require reading long descriptions to disambiguate.

Naming Consistency3/5

The names are mostly lowercase snake_case and readable, but there is no consistent verb_noun pattern: entity_profile and recent_changes are noun phrases, pipeworx_trending and pipeworx_feedback use a prefix, ask_pipeworx_beta is a single-family variant, and scan_competitor_ai_presence uses a different structure from ai_visibility_check. The naming is not chaotic, but it is a mix of conventions.

Tool Count1/5

A server labeled Microsoft Onenote exposes 31 tools, none of which actually relate to OneNote note-taking, notebooks, or pages. Even as a general research/prediction-market server, 31 tools is far above the coherent range, and for the stated product purpose this count is wildly inappropriate.

Completeness1/5

For the server's declared OneNote domain, there is zero coverage: no tools for creating, reading, updating, or deleting notes, pages, sections, or notebooks. The actual tool surface is centered on Pipeworx data lookups, Polymarket arbitrage, and memory helpers, which leaves the apparent note-taking domain completely unrepresented.

Resources